Bio-Rad Laboratories Inc. (BIO)

Sector:Technology
Super Investor Stats:
Ownership count:5
Ownership rank:93
% of all portfolios:0.126%
Hold Price * :$302.41
History Portfolio Manager Activity Share change % change to portfolio
Q3  2024
John Rogers - Ariel Appreciation Fund Add 29.05% 15,025 0.50
First Eagle Investment Management Add 12.06% 76,725 0.05
Charles Bobrinskoy - Ariel Focus Fund Buy 2,522 1.25
Q2  2024
First Eagle Investment Management Add 32296.89% 634,311 0.39
John Rogers - Ariel Appreciation Fund Add 51.36% 17,548 0.50
Steven Romick - FPA Crescent Fund Buy 152,000 0.65
Q1  2024
First Eagle Investment Management Add 310.02% 1,485 0.00
John Rogers - Ariel Appreciation Fund Buy 34,165 1.12
Q4  2023
Mason Hawkins - Longleaf Partners Add 14.53% 24,982 0.68
First Eagle Investment Management Add 4.59% 21 0.00
Q3  2023
First Eagle Investment Management Add 139.79% 267 0.00
Q2  2023
Mason Hawkins - Longleaf Partners Buy 171,987 4.95
First Eagle Investment Management Buy 191 0.00
Q1  2023
Lee Ainslie - Maverick Capital Add 385.35% 2,447 0.03
Q4  2022
Lee Ainslie - Maverick Capital Buy 635 0.01
Q2  2021
Lee Ainslie - Maverick Capital Add 22.42% 50 0.00
Q4  2020
Lee Ainslie - Maverick Capital Buy 416 0.00
Q2  2020
Lee Ainslie - Maverick Capital Buy 915 0.01
Q1  2015
Charles Bobrinskoy - Ariel Focus Fund Buy 5,000 1.05
Q3  2013
John Rogers - Ariel Appreciation Fund Add 24.51% 54,800 0.36
Q2  2012
John Rogers - Ariel Appreciation Fund Add 10.91% 22,000 0.17
Q3  2009
John Rogers - Ariel Appreciation Fund Add 28.25% 61,800 0.46
Q2  2009
John Rogers - Ariel Appreciation Fund Add 42.65% 65,400 0.52
Q1  2009
John Rogers - Ariel Appreciation Fund Buy 153,325 1.36

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.